Previous 10 | Next 10 |
Brain cancer is an aggressive type of cancer that starts developing in the brain. There are many types of spinal cord and brain tumors, which can be either malignant or benign. Malignant brain tumors often grow and spread rather quickly into other tissues. The latest data from the National Canc...
Scientists have found a new way to detect tumors in the brain using a device that picks out a certain protein in the urine. This noninvasive method will eliminate the need for invasive tests while also increasing the chances of tumors being detected earlier. Glioblastoma multiforme is a commo...
Enrollment in ongoing potentially pivotal study evaluating Berubicin for the treatment of GBM continues to rapidly progress toward planned interim analysis, expected in the third quarter of 2023 HOUSTON, TX / ACCESSWIRE / May 15, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or t...
While the treatment of cancer has improved significantly these past decade, brain metastases still have no cure. The clinical need for effective and targeted treatments continues to grow, as more patients are diagnosed with this fatal illness. New research recently discovered a protein found ...
A new study has led to the discovery of gene variants that may play a significant role in handing down glioma from a parent to their child. A glioma is a type of primary brain tumor that stems from glial cells, which support neuron function. Familial glioma usually affects members of the same...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Bettina M. Cockroft, M.D., M.B.A., to its board of directors. Dr. Coc...
Brings over 30 years of significant biopharmaceutical industry experience and proven clinical development and operational expertise across multiple therapeutic disciplines worldwide HOUSTON, TX / ACCESSWIRE / May 8, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"),...
2023-05-04 08:55:15 ET Enviva EVA -50% after Q1 earning release . First Horizon Corporation FHN -43% after merger with TD Bank ends. Sensus Healthcare SRTS -42% after Q1 earning release . PacWest Bancorp PACW -41% on confirming sale talks follow...
2023-05-03 10:01:41 ET Gainers: Aptorum ( APM ) +133% . ImmunoGen ( IMGN ) +123% . Akanda ( AKAN ) +63% . Mersana Therapeutics ( MRSN ) +37% . CNS Pharmaceuticals ( CNSP ) +25% . Losers: Assure ( IONM ) -38% ....
2023-05-03 09:56:57 ET CNS Pharmaceuticals ( NASDAQ: CNSP ) has retained Shareholder Intelligence Services to investigate trading patterns of its stock amidst potential naked short selling . "We have zero tolerance for illegal naked short selling and any other manipulation...
News, Short Squeeze, Breakout and More Instantly...
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NYSE Market:
CNS Pharmaceuticals Inc. Website:
New research suggests that cancer may have been plaguing individuals even thousands of years ago. Researchers at the University of Cambridge’s Duckworth Laboratory Collection studied skulls obtained from Ancient Egypt, observing lesions which they believe may have been left by malignant t...
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured in tomorrow’s Virtual Investor Closing Bell Series. According to the announcemen...
Live video webcast with Chief Executive Officer, John Climaco, on Wednesday, June 17 th at 4:00 PM ET HOUSTON, TX / ACCESSWIRE / July 16, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatm...